A5065224103- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Molecular Biology Techniques and Applications
- Colorectal and Anal Carcinomas
- Protease and Inhibitor Mechanisms
- Genetic factors in colorectal cancer
- Peptidase Inhibition and Analysis
- Metastasis and carcinoma case studies
Universidade Federal de Pernambuco
2021-2025
Matrix metalloproteinases (MMP) have been identified as biomarkers for several diseases, including cancer. The increase in the expression of these enzymes has related to greater tumor aggressiveness. MMP-26 is expressed constitutively endometrium and some cancer cells epithelial origin. However, there a lack studies on its prostatic carcinoma. In this study, evaluation reactivity by immunohistochemistry (IHC) was carried out 150 paraffinized samples representative benign malignant lesions....
ABSTRACT Introduction Matrix metalloproteinases (MMP) have been identified as biomarkers for several diseases, including cancer. MMP-26 is constitutively expressed in some cancer cells of epithelial origin. Despite this, there a lack studies regarding the expression on prostatic carcinoma. Aim Here, we investigate peptide benign and malign tissues. Patients Methods For 150 specimens, atrophy (N = 25), intraepithelial neoplasia (PIN) hyperplasia (BPH) 50), adenocarcinoma (PA) were...